220 POSTER Combination of class I PI3K inhibitor, GDC-0941, with standard of care therapeutics results in enhanced anti-tumor responses in human cancer models in vitro and in vivo
D. Sampath, M. Belvin, J. Guan, K. Edgar, J. Wallin, W.W. Prior, R. Kassees, P. Moore, S. Patel, L. FriedmanVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72152-9
File:
PDF, 74 KB
english, 2008